enGene Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Year Ending	Current	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021
Market Capitalization	397	503	160	-
Market Cap Growth	316.17%	213.58%	-	-
Enterprise Value	157	431	168	-8
PE Ratio	-	-4.80	-5.53	-
PB Ratio	1.63	6.94	-2.10	-
P/FCF Ratio	-	-20.08	-9.04	-
P/OCF Ratio	-	-20.34	-9.12	-
EV/EBITDA Ratio	-	-4.55	-7.39	0.42
EV/EBIT Ratio	-4.15	-4.54	-7.31	0.41
EV/FCF Ratio	-	-17.22	-9.48	0.46
Debt / Equity Ratio	0.10	0.13	-0.37	-0.07
Debt / EBITDA Ratio	-	-0.10	-1.24	-0.20
Debt / FCF Ratio	-	-0.39	-1.60	-0.22
Quick Ratio	42.05	15.52	4.02	3.45
Current Ratio	42.80	16.25	4.43	4.20
Interest Coverage	-28.01	-19.17	-16.17	-3.67
Return on Equity (ROE)	-162.40%	5074.60%	44.60%	-
Return on Assets (ROA)	-92.20%	-188.90%	-149.10%	-
Return on Capital (ROIC)	-16.73%	-31.68%	40.23%	31.81%
Earnings Yield	-29.03%	-20.81%	-18.08%	-
FCF Yield	-4.98%	-11.06%	-
Buyback Yield / Dilution	-5579.47%	-5.72%	81.61%	-28.93%
Total Shareholder Return	-5579.47%	-5.72%	81.61%	-28.93%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).